Ulixertinib Clinical Trials
5 recruitingDrug
Phase 13Phase 22Early Phase 11
Showing 1–5 of 5 trials
Recruiting
Early Phase 1
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
Gliomas
M.D. Anderson Cancer Center40 enrolled1 locationNCT05804227
Recruiting
Phase 2
Ulixertinib in People With Histiocytic Neoplasms
Histiocytic Neoplasms
Memorial Sloan Kettering Cancer Center38 enrolled8 locationsNCT06411821
Recruiting
Phase 1Phase 2
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Myelofibrosis
Memorial Sloan Kettering Cancer Center37 enrolled9 locationsNCT06773195
Recruiting
Phase 1
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
Metastatic Colorectal Cancer
M.D. Anderson Cancer Center27 enrolled1 locationNCT05985954
Recruiting
Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Pancreatic CancerMelanomaTumor, Solid
UNC Lineberger Comprehensive Cancer Center45 enrolled1 locationNCT03454035